<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686942</url>
  </required_header>
  <id_info>
    <org_study_id>Sonazoid001</org_study_id>
    <nct_id>NCT04686942</nct_id>
  </id_info>
  <brief_title>Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm</brief_title>
  <official_title>Evaluation of Contrast Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative chemotherapy is often used for patients with colorectal cancer liver metastasis&#xD;
      (CLM). Many small CLMs (&lt;=2cm) may disappear after chemotherapy, while most of these are&#xD;
      still alive. Ultrasonography (US) is a common imaging modality for the intraoperative&#xD;
      detection tumor. Sonazoid is new echo-contrast agent, which is more stable and sensitive for&#xD;
      detecting of small tumor. Investigators initially this prospective study to compare the&#xD;
      detection performance before and after using sonazoid.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 17, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sensitive of detection tumor</measure>
    <time_frame>6 months</time_frame>
    <description>Change of the sensitivity detection liver tumors when using sonazoid enhanced ultrasound</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Liver Metastasis Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Before sonazoid</arm_group_label>
    <description>US detection liver metastases before sonazoid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>After sonazoid</arm_group_label>
    <description>US detection liver metastases after sonazoid</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>After sonazoid</intervention_name>
    <description>0.015ml/mg sonazoid enhanced US to detection of liver metastases.</description>
    <arm_group_label>After sonazoid</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with one or more liver metastases lesions less than 2cm.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pathology confirmed colorectal adenocarcinoma&#xD;
&#xD;
          -  One or more liver metastases less than 2 cm&#xD;
&#xD;
          -  Multidisciplinary team recommend to perform preoperative chemotherapy&#xD;
&#xD;
          -  Have baseline EOB-MR before chemotherapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Could not fulfill the criteria of no evidence of disease (NED) after hepatic&#xD;
             resection/ablation/radiotherapy&#xD;
&#xD;
          -  With other malignancies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunfei Yuan, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiliang Qiu</last_name>
    <phone>862087343114</phone>
    <email>qiujl@sysucc.org.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xuzhi Pan</last_name>
    <phone>862087343009</phone>
    <email>panxzh@sysucc.org.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sun Yat-sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiliang Qiu</last_name>
      <phone>862087343114</phone>
      <email>qiujl@sysucc.org.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xuzhi Pan</last_name>
      <phone>862087343009</phone>
      <email>panxzh@sysucc.org.cn</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 27, 2020</last_update_submitted>
  <last_update_submitted_qc>December 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yunfei Yuan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

